ArticleJournal of translational medicine2026
A novel molecule ZYZ329 targeting histone methyltransferase SMYD3 suppresses pathological angiogenesis via the driven mitochondrial ROS/HIF-1α/VEGFA axis.
Qing Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.